Jp. Simons et al., The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction, LARYNGOSCOP, 111(2), 2001, pp. 329-335
Objectives/Hypothesis: Patients undergoing contaminated head and neck surge
ry with nap reconstruction have wound infection rates of 20% to 25% with pa
renteral antibiotic prophylaxis, Studies suggest that perioperative antimic
robial mouthwash reduces oropharyngeal flora and may prevent wound infectio
ns. We hypothesized that the addition of topical antibiotics to a parentera
l prophylactic regimen would reduce the incidence of wound infection in the
se high-risk patients. Study Design: We performed a randomized, prospective
clinical trial. Methods: Patients received either 1) parenteral piperacill
in/tazobactam (3.375 g every 6 hours for 48 h) or 2) parenteral piperacilli
n/tazobactam plus topical piperacillin/tazobactam administered as a mouthwa
sh immediately before surgery and once a day for 2 days postoperatively, wi
th piperacillin/tazobactam added to the intraoperative irrigation solution.
The wounds of all patients were evaluated daily using predefined objective
criteria Results: Sixty-two patients met inclusion criteria and were enrol
led in the study. The overall wound infection rate was 8.1% (95% confidence
interval [CII, 2.7%-17.8%). Two of 31 patients (6.4%) who received parente
ral antibiotics alone developed a wound infection compared with 3 of 31 pat
ients (9.7%) randomly assigned to receive topical plus parenteral antibioti
cs. This difference was not statistically significant (P = >.05). Infection
rate was: not associated with nap type (rotational vs. free tissue transfe
r), mandibular reconstruction, age, gender,tumor site, stage, surgical dura
tion, or blood loss. Conclusions: These results suggest that piperacillin/t
azobactam is a highly effective antibiotic for prevention of wound infectio
n in patients undergoing flap reconstruction following contaminated head an
d neck surgery, However, the addition of topical piperacillin/tazobactam do
es not appear to enhance the prophylactic benefit of parenteral antibiotics
alone.